Retatrutide appears to be a new pharmaceutical in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By activating these https://margiealcm379462.nizarblog.com/36418389/retatrutide-a-promising-new-treatment-for-obesity